Bright Health Group, Inc. (BHG) Stock Competitors & Peer Comparison
See (BHG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BHG | $16.35 | +9.36% | 130.5M | -0.12 | -$136.21 | N/A |
| UNH | $416.14 | -2.75% | 380.9B | 25.67 | $16.34 | +2.14% |
| CVS | $104.44 | +0.10% | 132.2B | 14.65 | $7.07 | +2.57% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $388.61 | -1.66% | 84.2B | 12.60 | $30.78 | +1.77% |
| CI | $278.07 | -1.67% | 73.7B | 9.02 | $30.90 | +2.19% |
| HUM | $397.17 | +3.47% | 46.7B | 24.55 | $15.86 | +0.91% |
| CNC | $64.12 | -2.45% | 31.9B | 25.61 | $2.52 | N/A |
| MOH | $229.03 | -0.31% | 12B | 33.17 | $6.92 | N/A |
| OSCR | $28.70 | -3.66% | 7.6B | -49.88 | -$0.59 | N/A |
Stock Comparison
BHG vs UNH Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, UNH has a market cap of 380.9B. Regarding current trading prices, BHG is priced at $16.35, while UNH trades at $416.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas UNH's P/E ratio is 25.67. In terms of profitability, BHG's ROE is -0.70%, compared to UNH's ROE of +0.12%. Regarding short-term risk, BHG is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check UNH's competition here
BHG vs CVS Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, CVS has a market cap of 132.2B. Regarding current trading prices, BHG is priced at $16.35, while CVS trades at $104.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas CVS's P/E ratio is 14.65. In terms of profitability, BHG's ROE is -0.70%, compared to CVS's ROE of +0.04%. Regarding short-term risk, BHG is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check CVS's competition here
BHG vs ANTM Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, BHG is priced at $16.35, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas ANTM's P/E ratio is 18.99. In terms of profitability, BHG's ROE is -0.70%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, BHG is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check ANTM's competition here
BHG vs ELV Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, ELV has a market cap of 84.2B. Regarding current trading prices, BHG is priced at $16.35, while ELV trades at $388.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas ELV's P/E ratio is 12.60. In terms of profitability, BHG's ROE is -0.70%, compared to ELV's ROE of +0.12%. Regarding short-term risk, BHG is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check ELV's competition here
BHG vs CI Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, CI has a market cap of 73.7B. Regarding current trading prices, BHG is priced at $16.35, while CI trades at $278.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas CI's P/E ratio is 9.02. In terms of profitability, BHG's ROE is -0.70%, compared to CI's ROE of +0.15%. Regarding short-term risk, BHG is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check CI's competition here
BHG vs HUM Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, HUM has a market cap of 46.7B. Regarding current trading prices, BHG is priced at $16.35, while HUM trades at $397.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas HUM's P/E ratio is 24.55. In terms of profitability, BHG's ROE is -0.70%, compared to HUM's ROE of +0.06%. Regarding short-term risk, BHG is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check HUM's competition here
BHG vs CNC Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, CNC has a market cap of 31.9B. Regarding current trading prices, BHG is priced at $16.35, while CNC trades at $64.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas CNC's P/E ratio is 25.61. In terms of profitability, BHG's ROE is -0.70%, compared to CNC's ROE of -0.29%. Regarding short-term risk, BHG is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check CNC's competition here
BHG vs MOH Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, MOH has a market cap of 12B. Regarding current trading prices, BHG is priced at $16.35, while MOH trades at $229.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas MOH's P/E ratio is 33.17. In terms of profitability, BHG's ROE is -0.70%, compared to MOH's ROE of +0.04%. Regarding short-term risk, BHG is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check MOH's competition here
BHG vs OSCR Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, OSCR has a market cap of 7.6B. Regarding current trading prices, BHG is priced at $16.35, while OSCR trades at $28.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas OSCR's P/E ratio is -49.88. In terms of profitability, BHG's ROE is -0.70%, compared to OSCR's ROE of -0.03%. Regarding short-term risk, BHG is more volatile compared to OSCR. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check OSCR's competition here
BHG vs ALHC Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, ALHC has a market cap of 4.8B. Regarding current trading prices, BHG is priced at $16.35, while ALHC trades at $23.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas ALHC's P/E ratio is 258.44. In terms of profitability, BHG's ROE is -0.70%, compared to ALHC's ROE of +0.11%. Regarding short-term risk, BHG is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check ALHC's competition here
BHG vs CLOV Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, CLOV has a market cap of 2.8B. Regarding current trading prices, BHG is priced at $16.35, while CLOV trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas CLOV's P/E ratio is -44.25. In terms of profitability, BHG's ROE is -0.70%, compared to CLOV's ROE of -0.17%. Regarding short-term risk, BHG is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check CLOV's competition here
BHG vs CABR Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, CABR has a market cap of 18.6M. Regarding current trading prices, BHG is priced at $16.35, while CABR trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas CABR's P/E ratio is -2.17. In terms of profitability, BHG's ROE is -0.70%, compared to CABR's ROE of -3.00%. Regarding short-term risk, BHG is more volatile compared to CABR. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check CABR's competition here
BHG vs BMGL Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, BMGL has a market cap of 10.6M. Regarding current trading prices, BHG is priced at $16.35, while BMGL trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas BMGL's P/E ratio is -1.29. In terms of profitability, BHG's ROE is -0.70%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, BHG is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for BHG.Check BMGL's competition here
BHG vs AET Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, AET has a market cap of 0. Regarding current trading prices, BHG is priced at $16.35, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas AET's P/E ratio is 9.57. In terms of profitability, BHG's ROE is -0.70%, compared to AET's ROE of +0.11%. Regarding short-term risk, BHG is more volatile compared to AET. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check AET's competition here
BHG vs GTS Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, GTS has a market cap of 0. Regarding current trading prices, BHG is priced at $16.35, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas GTS's P/E ratio is 10.41. In terms of profitability, BHG's ROE is -0.70%, compared to GTS's ROE of +0.07%. Regarding short-term risk, BHG is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check GTS's competition here
BHG vs MGLN Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, MGLN has a market cap of 0. Regarding current trading prices, BHG is priced at $16.35, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas MGLN's P/E ratio is 8.49. In terms of profitability, BHG's ROE is -0.70%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, BHG is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check MGLN's competition here
BHG vs UAM Comparison July 2026
BHG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHG stands at 130.5M. In comparison, UAM has a market cap of 0. Regarding current trading prices, BHG is priced at $16.35, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHG currently has a P/E ratio of -0.12, whereas UAM's P/E ratio is 1.01. In terms of profitability, BHG's ROE is -0.70%, compared to UAM's ROE of +0.17%. Regarding short-term risk, BHG is more volatile compared to UAM. This indicates potentially higher risk in terms of short-term price fluctuations for BHG.Check UAM's competition here